Friday 6 November 2026 Export EW’s income statement to Excel — free account

Edwards Lifesciences Corporation

EW Healthcare Medical Devices

Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024.

Revenue: +10.5%
EPS: +6.00%
Free cash flow: −1.84%
Total debt: +0.10%

Quarter to September 2026, against a year earlier

101.94 1.12 +1.11%

Follow EW

Alert me

Market cap: $58.1B
P/E: 56.7×
Fwd P/E: 36.5×
Dividend yield: —
F-score: 5/9
Altman Z: 11.54
Beneish M: −2.48
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Edwards Lifesciences Corporation 10-K filed Feb 28, 2025

Fiscal year 2024 · Period ended Dec 31, 2024 · Filed Feb 28, 2025 · accepted 4:50 PM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 1, Business: no comparison — no earlier filing on file